All Stories

  1. Accurate Post-Calibration Predictions for Noninvasive Glucose Measurements in People Using Confocal Raman Spectroscopy
  2. A Statistical Approach for Assessing the Compliance of Integrated Continuous Glucose Monitoring Systems with Food and Drug Administration Accuracy Requirements
  3. Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial
  4. User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Measurement Results
  5. Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems
  6. Improving the Bias of Comparator Methods in Analytical Performance Assessments Through Recalibration
  7. Suitability of continuous glucose monitoring in healthy subjects to detect effects of meal sequences and nutritional content of meals on postprandial glycemic responses
  8. Real-Time Continuous Glucose Monitoring Can Predict Severe Hypoglycemia in People with Type 1 Diabetes: Combined Analysis of the HypoDE and DIAMOND Trials
  9. Continuous Glucose Profiles in Healthy People With Fixed Meal Times and Under Everyday Life Conditions
  10. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland
  11. Accuracy Evaluation of a Novel Reusable Patch Pump Prototype
  12. Patch Pumps: What are the advantages for people with diabetes?
  13. Patch Pumps: Periodic Insulin Delivery Patterns
  14. Definition, Classification and Diagnosis of Diabetes Mellitus
  15. Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus
  16. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes
  17. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
  18. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland
  19. Impact of Blood Glucose Monitoring System Accuracy on Clinical Decision Making for Diabetes Management
  20. Evaluation of the Accuracy and Reliability of a Tubeless Insulin Infusion System Under Laboratory Conditions
  21. Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis
  22. Response to Seibold: Data Obtained With Early Generations of CGM Sensors: Comment on Pleus et al.
  23. Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics Between 2016 and 2019 in Germany
  24. Glukosemessung in der Diabetesdiagnostik und -therapie: Laboratoriumsmedizinische Untersuchung inkl. patientennaher Sofortdiagnostik, Blutglukoseselbstmessung und kontinuierliches Glukosemonitoring
  25. Entwicklung und psychometrische Evaluation eines herstellerunabhängigen Wissenstests zum kontinuierlichen Glukosemonitoring in Echtzeit für insulinbehandelte Menschen mit Diabetes
  26. Comment on “Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory” by Spanou and Makris
  27. Evaluation of Meal Carbohydrate Counting Errors in Patients with Type 1 Diabetes
  28. Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
  29. Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study
  30. Standardization process of continuous glucose monitoring: Traceability and performance
  31. Mean Absolute Relative Difference of Blood Glucose Monitoring Systems and Relationship to ISO 15197
  32. Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation
  33. Diabetesdiagnostik in der Hausarztpraxis
  34. Methoden der Stoffwechselkontrolle – HbA1c versus „time in range“
  35. Variation of Mean Absolute Relative Differences of Continuous Glucose Monitoring Systems Throughout the Day
  36. Evaluation of Trueness and Precision of a Bench-Top Laboratory Glucose Analyzer Using Reference Materials
  37. Choice of Continuous Glucose Monitoring Systems May Affect Metrics: Clinically Relevant Differences in Times in Ranges
  38. Evaluation of the SPECTRUM training programme for real‐time continuous glucose monitoring: A real‐world multicentre prospective study in 120 adults with type 1 diabetes
  39. Diabetesdiagnostik in der Praxis
  40. Diabetesdiagnostik in der Hausarztpraxis
  41. Diagnostik des Gestationsdiabetes mellitus in der Praxis
  42. Stability of Glucose Concentrations in Frozen Plasma
  43. A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control
  44. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline
  45. Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems
  46. Proof of Concept for a New Raman-Based Prototype for Noninvasive Glucose Monitoring
  47. Der Auftragsverarbeitungsvertrag (AV-Vertrag): Relevanz und praktische Bedeutung für die Diabetologie
  48. Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score
  49. Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics
  50. Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies
  51. Skin Reaction Report Form: Development and Design of a Standardized Report Form for Skin Reactions Due to Medical Devices for Diabetes Management
  52. The YSI 2300 Analyzer Replacement Meeting Report
  53. Measurement accuracy of two professional-use systems for point-of-care testing of blood glucose
  54. Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
  55. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents
  56. Basics and use of continuous glucose monitoring (CGM) in diabetes therapy
  57. System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015
  58. Comparative Accuracy Analysis of a Real-time and an Intermittent-Scanning Continuous Glucose Monitoring System
  59. Definition, Classification and Diagnosis of Diabetes Mellitus
  60. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes
  61. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
  62. Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature
  63. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia
  64. Concept and Implementation of a Novel Patch Pump for Insulin Delivery
  65. Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space
  66. 119-LB: Bolus Dosing Accuracy of Two Recent Insulin Pumps
  67. 279-OR: How to Use rtCGM Data to Predict Future Severe Hypoglycemia?
  68. Advanced carbohydrate counting: An engineering perspective
  69. Deviation Analysis and Interval Modeling as Complementary Tools to Evaluate Insulin Dosing Algorithms in Diabetes
  70. Entwicklung und teststatistische Prüfung eines Wissenstests zum rtCGM (real-time continuous glucose monitoring): „rtCGM-Profi-Check“
  71. Genauigkeit verschiedener Insulinpumpen bei der Abgabe von Basalraten unter Verwendung eines typischen zirkadianen Profils mit zusätzlichen Bolusabgaben
  72. Kontinuierliches Glukosemonitoring bei Menschen ohne Diabetes nach vordefinierten Mahlzeiten und im Alltag
  73. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems
  74. Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study
  75. Proof of Concept Study to Assess the Influence of Oxygen Partial Pressure in Capillary Blood on SMBG Measurements
  76. Performance and Usability of Three Systems for Continuous Glucose Monitoring in Direct Comparison
  77. The Effects and Effect Sizes of Real-Time Continuous Glucose Monitoring on Patient-Reported Outcomes: A Secondary Analysis of the HypoDE Study
  78. Comment on �accuracy and precision of four main glucometers used in a sub-Saharan African country: a cross-sectional study� by Choukem et al
  79. Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments
  80. Assessment of System Accuracy, Intermediate Measurement Precision, and Measurement Repeatability of a Blood Glucose Monitoring System Based on ISO 15197
  81. Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices
  82. Reporting Insulin Pump Accuracy: Trumpet Curves According to IEC 60601-2-24 and Beyond
  83. Evaluation of Analytical Performance of Three Blood Glucose Monitoring Systems: System Accuracy, Measurement Repeatability, and Intermediate Measurement Precision
  84. Correction: Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
  85. Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
  86. Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
  87. Patch Pumps: Are They All the Same?
  88. Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose MonitoringParts of the data have previously been presented at the 77th Scientific Sessions of the American Diabetes Association in San...
  89. Prediction Quality of Glucose Trend Indicators in Two Continuous Tissue Glucose Monitoring SystemsParts of these data were previously presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes, September 11–15, 2017, Lis...
  90. Accuracy of five systems for self-monitoring of blood glucose in the hands of adult lay-users and professionals applying ISO 15197:2013 accuracy criteria and potential insulin dosing errors
  91. Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps
  92. First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
  93. Definition, Classification and Diagnosis of Diabetes Mellitus
  94. Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany
  95. Definition, classification and diagnostics of diabetes mellitus
  96. Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials
  97. Evaluation of Hematocrit Influence on Measurements With a Novel Self-Monitoring of Blood Glucose System Based on ISO 15197:2013
  98. Basal Rate Delivery of Different Insulin Pumps—An Accuracy Evaluation
  99. Delivery of Low Basal Rates in Different Insulin Pumps—An Accuracy Evaluation
  100. Predictors of Hypoglycemia Avoidance in a Randomized Controlled rtCGM Trial (HypoDE)
  101. The Relationship between A1C and Hypoglycemia in the HypoDE Study
  102. Evaluation of Four Blood Glucose Monitoring Systems for Self-Testing with Built-in Insulin Dose Advisor Based on ISO 15197:2013: System Accuracy and Hematocrit Influence
  103. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
  104. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors
  105. Blood Glucose Monitoring Data Should Be Reported in Detail When Studies About Efficacy of Continuous Glucose Monitoring Systems Are Published
  106. System Accuracy and User Performance Evaluation of an Improved System for Self-Monitoring of Blood Glucose
  107. Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?
  108. Identification of Mixed-Meal Effects on Insulin Needs and Glycemic Control
  109. Impact of Carbohydrate Counting Errors on Glycemic Control in Type 1 Diabetes
  110. Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates
  111. HbA1c-POC-Systeme zur Therapiekontrolle und Diagnostik des Diabetes: Ausreichende Qualität und Qualitätskontrolle?
  112. Flash Glucose Monitoring: Differences Between Intermittently Scanned and Continuously Stored Data
  113. Accuracy Evaluation of a New System for Self-Monitoring of Blood Glucose With Three Test Strip Lots Based on ISO 15197:2013
  114. Comparative Handling Analysis of Different Insulin Pump Systems
  115. Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study
  116. ISO 15197: 2013 Evaluation of a Blood Glucose Monitoring System’s Measurement Accuracy
  117. Evaluation of Accuracy of Six Blood Glucose Monitoring Systems and Modeling of Possibly Related Insulin Dosing Errors
  118. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View
  119. Do the New FDA Guidance Documents Help Improving Performance of Blood Glucose Monitoring Systems Compared With ISO 15197?
  120. Introduction of a Novel Smartphone-Coupled Blood Glucose Monitoring System
  121. Strengths and Limitations of New Approaches for Graphical Presentation of Blood Glucose Monitoring System Accuracy Data
  122. Accuracy Evaluation of Four Blood Glucose Monitoring Systems in the Hands of Intended Users and Trained Personnel Based on ISO 15197 Requirements
  123. Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block
  124. Accuracy Assessment of an Improved Version of an Established Blood Glucose Monitoring System for Self-Testing Following ISO 15197:2013
  125. Continuous glucose monitoring: A training programme for all age groups
  126. Bolus Calculator Safety Mandates a Need for Standards
  127. Regulatorische Defizite bei Medizinprodukten
  128. Accuracy and user performance evaluation as key factors in self-monitoring in diabetes patients
  129. Significance and Reliability of MARD for the Accuracy of CGM Systems
  130. Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind
  131. Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life
  132. Deviation analysis of clinical studies as tool to tune and assess performance of diabetes control algorithms
  133. SPECTRUM
  134. Boluses in Insulin Therapy
  135. Interferences and Limitations in Blood Glucose Self-Testing
  136. Comment on “The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System” by Bailey et al.
  137. Performance of two updated blood glucose monitoring systems: an evaluation following ISO 15197:2013
  138. Continuous Glucose Monitoring in 2015
  139. Self-Monitoring of Blood Glucose
  140. Identification of CGM Time Delays and Implications for BG Control in T1DM
  141. Positionspapier der Kommission für Labordiagnostik in der Diabetologie der DGKL und der DDG
  142. Can We Use Measurements to Classify Patients Suffering from Type 1 Diabetes into Subcategories and Does It Make Sense?
  143. Accuracy of BG Meters and CGM Systems: Possible Influence Factors for the Glucose Prediction Based on Tissue Glucose Concentrations
  144. The Rectangle Target Plot
  145. Accuracy Evaluation of an Integrated Blood Glucose Monitoring System With Improved Test Cassettes Following ISO 15197:2013
  146. Updated Requirements for Measurement Quality and Quality Assurance of Point-Of-Care Testing (POCT) – Blood Glucose Measurement Systems with Unit-Use Reagents Suitable for the Initial Diagnosis of Diabetes Manifested in Pregnancy or Gestational Diabetes...
  147. CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring
  148. Performance Comparison of CGM Systems
  149. Accuracy Evaluation of Four Blood Glucose Monitoring Systems in Unaltered Blood Samples in the Low Glycemic Range and Blood Samples in the Concentration Range Defined by ISO 15197
  150. System Accuracy Evaluation of Different Blood Glucose Monitoring Systems Following ISO 15197:2013 by Using Two Different Comparison Methods
  151. Time Delay of CGM Sensors
  152. Performance of Blood Glucose Meters in the Low-Glucose Range: Current Evaluations Indicate That It Is Not Sufficient From a Clinical Point of View
  153. Identification of diurnal patterns in insulin action from measured CGM data for patients with T1DM
  154. Diagnostik des Gestationsdiabetes: Die Crux liegt bei der Blutentnahme
  155. ISO 15197:2013 Accuracy Evaluation of Two CE-Marked Systems for Self-Monitoring of Blood Glucose
  156. Neue Technologien in der Diabetologie
  157. System Accuracy Evaluation of Four Systems for Self-Monitoring of Blood Glucose Following ISO 15197 Using a Glucose Oxidase and a Hexokinase-Based Comparison Method
  158. Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy
  159. Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings
  160. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)
  161. Quality of HbA1c Measurement in the Practice
  162. Aktualisierte Anforderungen an die Messqualität und Qualitätssicherung (QS) von Point-of-Care-Testing (POCT)-Blutglukose-Messsystemen mit Unit-use Reagenzien, die für die Erstdiagnostik eines manifesten Diabetes in der Schwangerschaft oder eines Gestat...
  163. Performance assessment of estimation methods for CIR/ISF in bolus calculators∗∗This work has been supported by the Linz Center of Mechatronics (LCM) in the framework of the Austrian COMET-K2 program
  164. LMI-based online estimation of a time-varying time-delay in continuous glucose measurement devices
  165. Use of Microdialysis-Based Continuous Glucose Monitoring to Drive Real-Time Semi-Closed-Loop Insulin Infusion
  166. Self-Monitoring of Blood Glucose
  167. Accuracy Assessment of an Advanced Blood Glucose Monitoring System for Self-Testing With Three Reagent System Lots Following ISO 15197:2013
  168. Model of the glucose-insulin system of type-1 diabetics and optimization-based bolus calculation
  169. Short-term prediction of blood glucose concentration using interval probabilistic models
  170. Accuracy Assessment of Two Novel Systems for Self-Monitoring of Blood Glucose Following ISO 15197:2013
  171. Accuracy Evaluation of Three Systems for Self-monitoring of Blood Glucose With Three Different Test Strip Lots Following ISO 15197
  172. Impact of Partial Pressure of Oxygen in Blood Samples on the Performance of Systems for Self-Monitoring of Blood Glucose
  173. Evaluation of 12 Blood Glucose Monitoring Systems for Self-Testing: System Accuracy and Measurement Reproducibility
  174. A-/B-Blutzuckermesssysteme
  175. Konsequenzen der Genauigkeit von Blutglucosemesssystemen
  176. Diabetestechnologie
  177. Auf dem Weg zum „Closed-loop“-System
  178. System accuracy evaluation of systems for point-of-care testing of blood glucose: a comparison of a patient-use system with six professional-use systems
  179. Influence of Partial Pressure of Oxygen in Blood Samples on Measurement Performance in Glucose-Oxidase-Based Systems for Self-Monitoring of Blood Glucose
  180. Partial Pressure of Oxygen in Capillary Blood Samples from the Fingertip
  181. In Response to Teodorczyk and Coauthors: System Accuracy of Blood Glucose Monitoring Devices According to the Current and Proposed ISO 15197 Standards
  182. Assessing the Analytical Performance of Systems for Self-Monitoring of Blood Glucose: Concepts of Performance Evaluation and Definition of Metrological Key Terms
  183. System Accuracy of Blood Glucose Monitoring Systems: Impact of Use by Patients and Ambient Conditions
  184. Performance Evaluation of a Continuous Glucose Monitoring System under Conditions Similar to Daily Life
  185. Evaluation of the Performance of a Novel System for Continuous Glucose Monitoring
  186. Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel
  187. Effect of Infusion Rate and Indwelling Time on Tissue Resistance Pressure in Small-Volume Subcutaneous Infusion like in Continuous Subcutaneous Insulin Infusion
  188. Considerations for an Institution for Evaluation of Diabetes Technology Devices to Improve Their Quality in the European Union
  189. Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use
  190. System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose according to DIN EN ISO 15197
  191. Lot-to-Lot Variability of Test Strips and Accuracy Assessment of Systems for Self-Monitoring of Blood Glucose according to ISO 15197
  192. Increasing Local Blood Flow by Warming the Application Site: Beneficial Effects on Postprandial Glycemic Excursions
  193. Feasibility of Overnight Closed-Loop Control Based on Hourly Blood Glucose Measurements
  194. Integrated Self-Monitoring of Blood Glucose System: Handling Step Analysis
  195. Accuracy in Blood Glucose Measurement: What Will a Tightening of Requirements Yield?
  196. Clinical Performance of a Device That Applies Local Heat to the Insulin Infusion Site: A Crossover Study
  197. Blutzuckermessgeräte
  198. Clinical Performance of Three Bolus Calculators in Subjects with Type 1 Diabetes Mellitus: A Head-to-Head-to-Head Comparison
  199. System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197
  200. Experimentelle Untersuchungen und klinische Evidenz der Insulinpumpentherapie (CSII)
  201. Glucose monitoring by microdialysis: performance in a multicentre study
  202. The Clinical Research Tool: A High-Performance Microdialysis-Based System for Reliably Measuring Interstitial Fluid Glucose Concentration
  203. The Circadian Study:: The Get-Up Phenomenon in Type 1 Diabetes
  204. Continuous Glucose Profiles in Healthy Subjects under Everyday Life Conditions and after Different Meals
  205. Recent advances in continuous glucose monitoring